Proposed Marketing Strategy of Healthcare IVD Distributor Post Covid 19 Pandemic (Case Study of PT. Sinergy Diagnostic)

Abstract

With the passage of time and the enhancement of societal well-being, there has been an increasing demand for health services within the community. The COVID-19 pandemic has had a profound effect on worldwide health systems and has caused a substantial overhaul in the healthcare industry. PT. Sinergy Diagnostic has been a distributor of In Vitro Diagnostics (IVD) for over 17 years and has catered to several clients. These establishments encompass medical laboratories, clinics, hospitals, and public institutions that are owned by both private and government entities effectively demonstrates the strategic implementation of Operation Cooperation (KSO). Amidst the pandemic, the company witnessed a significant surge in sales of Point of Care Testing (POCT), which can be attributed to the increased demand for quick diagnostic testing. Nevertheless, since the epidemic has concluded, the need for POCT is expected to decrease, presenting a potential threat to the company’s sales revenue, which became increasingly dependent on this category throughout the pandemic period. PT Sinergy Diagnostic must reassess its business plan and adjust to the evolving market conditions in order to maintain its company performance. For solving the problem, this study utilize a mixed research methodology, internally assesses PT Sinergy Diagnostic’s market position and operational capabilities through the application of the STP Analysis, Marketing Mix 7Ps, and the VRIO Analysis. For external, customer analysis conducted using interview method involved a total of 15 respondents and analysis of the data using descriptive statistical methods.